Oct 11 (Reuters) - Intellipharmaceutics International Inc
* Intellipharmaceutics signs an exclusive license and commercial supply agreement with mallinckrodt
* Intellipharmaceutics international inc - Intellipharmaceutics will receive a non-refundable upfront payment of US$3 million in October 2016
* Intellipharmaceutics International Inc - has agreed to manufacture and supply licensed products exclusively for mallinckrodt
* Intellipharmaceutics international inc - Mallinckrodt has agreed that Intellipharmaceutics will be its sole supplier of licensed products marketed in u.s
* Intellipharmaceutics International- agreement provides for company to have long-term profit sharing arrangement with respect to licensed products Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.